Safety of Phage Therapy Evident in Cystic Fibrosis Patients With Persistent Pseudomonas aeruginosa Infection
BiomX Develops BX004-A, a Phage Therapy, for Cystic Fibrosis Patients with Pseudomonas Infections. A phase 1b/2a study presents promising results at IDWeek 2023.
Source: infectioncontroltoday.com